Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Founder facing gender bias: Don’t call me a victim; call me investors
It’s like pulling teeth to get key investors and resource organizations to help push female entrepreneurs forward, said Carlanda McKinney, citing implicit bias and a lack of effective support mechanisms. “I don’t think it’s intentional at all. I think it’s a byproduct,” said McKinney, co-founder of Raaxo, an online tech platform used to design and…
Even gatekeepers struggle to bring KC’s women-led companies in from the cold
Female entrepreneurs are falling behind as a new generation of highly-scalable startups rises in the Kansas City, said Darcy Howe, reporting too few women-led firms even approaching KCRise Fund for investment. “My experience with those ‘Hey, I hear you have money’ calls that I do get [from female entrepreneurs] — many of them are not…
ScaleUP! KC reveals new 15-member cohort of growing businesses; touts alumni successes
Entrepreneurs joining the latest ScaleUP! Kansas City cohort represent ventures from such varied business sectors as photography, construction, design, counseling, film and engineering, said Jill Meyer. An ability to scale knows no single industry, emphasized Meyer, program director of ScaleUP! KC. “This program has shown us, time and time again, that not only can you…
Sweet & Sassy side hustle: Father-son duo behind Brownie’s bottles a venture to savor
Side hustles of any flavor can provide relief from the daily grind of a stressful startup, said Venture Legal’s Chris Brown of his “hobby” — delivering the homemade Sweet & Sassy Brownie’s Barbecue sauce. “Whether you like hiking or making barbecue sauce or riding horses or doing whatever … I think it’s important for people…